[go: up one dir, main page]

AU2002211279A1 - Antibodies to the propeptide of candida albicans and methods of use - Google Patents

Antibodies to the propeptide of candida albicans and methods of use

Info

Publication number
AU2002211279A1
AU2002211279A1 AU2002211279A AU1127902A AU2002211279A1 AU 2002211279 A1 AU2002211279 A1 AU 2002211279A1 AU 2002211279 A AU2002211279 A AU 2002211279A AU 1127902 A AU1127902 A AU 1127902A AU 2002211279 A1 AU2002211279 A1 AU 2002211279A1
Authority
AU
Australia
Prior art keywords
propeptide
antibodies
methods
candida albicans
albicans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211279A
Inventor
Denise Devore-Carter
Margaret K. Hostetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU2002211279A1 publication Critical patent/AU2002211279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002211279A 2000-09-28 2001-09-28 Antibodies to the propeptide of candida albicans and methods of use Abandoned AU2002211279A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23708200P 2000-09-28 2000-09-28
US60237082 2000-09-28
PCT/US2001/030312 WO2002026257A1 (en) 2000-09-28 2001-09-28 Antibodies to the propeptide of candida albicans and methods of use

Publications (1)

Publication Number Publication Date
AU2002211279A1 true AU2002211279A1 (en) 2002-04-08

Family

ID=22892264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211279A Abandoned AU2002211279A1 (en) 2000-09-28 2001-09-28 Antibodies to the propeptide of candida albicans and methods of use

Country Status (5)

Country Link
EP (1) EP1333860A4 (en)
JP (1) JP2004509923A (en)
AU (1) AU2002211279A1 (en)
CA (1) CA2423797A1 (en)
WO (1) WO2002026257A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006050343A2 (en) * 2004-10-29 2006-05-11 Yale University Monoclonal antibodies to the propeptide of candida albicans and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031998A1 (en) * 1994-05-23 1995-11-30 The Research & Development Institute, Inc. Candida albicans adhesin as a vaccine
US5886151A (en) * 1996-05-03 1999-03-23 Regents Of The University Of Minnesota Candida albicans integrin-like protein

Also Published As

Publication number Publication date
CA2423797A1 (en) 2002-04-04
EP1333860A4 (en) 2005-08-10
EP1333860A1 (en) 2003-08-13
WO2002026257A1 (en) 2002-04-04
JP2004509923A (en) 2004-04-02

Similar Documents

Publication Publication Date Title
WO2002030986A3 (en) HUMANIZED ANTI-LT-β-R ANTIBODIES
AU2002340167A1 (en) Anti-hla-dr antibodies and the methods of using thereof
ZA200305825B (en) Modified antibodies and methods of use
AU2001234473A1 (en) Stabilized silica and methods of making and using the same
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001245928A1 (en) Electrolyzer and method of using the same
AU2001278076A1 (en) Bstp-5 proteins and related reagents and methods of use thereof
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2001265346A1 (en) Artificial antigen presenting cells and methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001284816A1 (en) Multifunctional battery and method of making the same
AU2002224808A1 (en) Use of thienopyrimidines
AU2001290323A1 (en) Electrochemical device and method of manufacturing the device
AU2001275007A1 (en) Methods of testing materials
AU2002211183A1 (en) Prosthetic construct and methods for its manufacture and use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
AU2002237253A1 (en) Biosensor and method of producing the same
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2002211279A1 (en) Antibodies to the propeptide of candida albicans and methods of use
AU2002214333A1 (en) Method of assaying antilaminin-1 antibody and application thereof
AU2002321440A1 (en) Expression of modified antibodies in avian cells
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof